Christopher Chapman, MD, Assistant Professor of Medicine, Director of Bariatric and Metabolic Endoscopy, Department of Medicine at the University of Chicago, provides an overview of his research, specifically detailing the area of gastroenterology and his work with patients.
Dr. Chapman has extensive training and experience in Interventional Endoscopy and Gastroenterology. He is a noted gastroenterologist and member of the Center for Endoscopic Research and Therapeutics (CERT), where he regularly treats patients who suffer from various gastrointestinal disorders, through the use of minimally invasive endoscopic techniques.
The research doctor discusses his background at Johns Hopkins University, and now at the University of Chicago, and also his current work, which he describes as about 80% clinical and 20% research. As he explains, a good deal of his work deals with endoscopic procedures designed to help people lose weight, so they can improve their health, and reduce or eliminate their obesity-related conditions.
He explains how these procedures differ from bariatric surgery.
As he states, many of these procedures are done through the ‘natural orifice’ meaning they go in through the mouth while the patient is asleep. He provides an overview of the intragastric balloon procedure, which essentially inserts a balloon-type device inside your stomach that allows you to feel fuller faster; endoscopic sleeve gastroplasty (ESG), which reduces the size of the stomach; and then aspiration therapy, which is a bariatric approach that can help to siphon ingested food out of the stomach through an implanted tube and port it to the outside of the body to then be discarded.
Dr. Chapman discusses the many ways they, as researchers and doctors, seek to innovate in the space, applying new procedures and techniques to aid their patients with a wide assortment of medical maladies. He talks about clinical trials for their balloon devices, devices that can help people lose more weight and/or make the balloon more tolerable to patients who have difficulty.
He talks about other options in clinical trials, that focus on diabetes, and also some that are endoscopy-free. Many new techniques are on the horizon that will be minimally invasive, yet still, provide immense benefits to patients.
Continuing, Dr. Chapman talks about the work they are doing to try to get insurance companies to cover certain procedures, which will help those who may be underinsured or facing financial struggles, to get procedures they need for their health.